nerolidol has been researched along with Animal Mammary Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrož, M; Caltová, K; Hanušová, V; Králová, V; Murínová, N; Skálová, L; Skarka, A; Svobodová, H; Tomšík, P | 1 |
1 other study(ies) available for nerolidol and Animal Mammary Carcinoma
| Article | Year |
|---|---|
The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Female; Humans; Inhibitory Concentration 50; Mammary Neoplasms, Animal; Mice; Polycyclic Sesquiterpenes; Sesquiterpenes; Treatment Outcome | 2017 |